Screener
Amneal Pharmaceuticals, Inc. AMRX Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Amneal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: Amneal Pharmaceuticals, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 5:19 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001723128-26-000031
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Inventories | 677,954 | 606,302 |
| Prepaid expenses and other current assets | 112,011 | 98,395 |
| Related party receivables | 424 | 470 |
| Total current assets | 1,947,029 | 1,911,181 |
| Property, plant and equipment, net | 456,877 | 442,950 |
| Goodwill | 593,499 | 595,470 |
| Intangible assets, net | 587,830 | 563,498 |
| Operating lease right-of-use assets | 44,361 | 38,832 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Amneal Pharmaceuticals, Inc.'s total current assets?
- Amneal Pharmaceuticals, Inc. (AMRX) reported total current assets of $1.95B in Q2 2026.
- How has Amneal Pharmaceuticals, Inc.'s total current assets changed year-over-year?
- Amneal Pharmaceuticals, Inc.'s total current assets increased by 22.9% year-over-year, from $1.58B to $1.95B.
- What is the long-term trend for Amneal Pharmaceuticals, Inc.'s total current assets?
- Over 5 years (2020 to 2025), Amneal Pharmaceuticals, Inc.'s total current assets has grown at a 4.3% compound annual growth rate (CAGR), from $1.55B to $1.91B.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about Amneal Pharmaceuticals, Inc.'s total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude